#Salvectors
LightNews LightNews
newsen.bsky.social
Porton Advanced’s Innovative Solutions Propel Salvectors' Therapy Approval in China and the US#China#Suzhou#Porton_Advanced#Oncolytic_Therapy#Salvectors
Porton Advanced’s Innovative Solutions Propel Salvectors' Therapy Approval in China and the US
Porton Advanced's comprehensive CDMO services have successfully accelerated Salvectors' innovative oncolytic bacteria therapy approval in the US and China.
third-news.com
May 28, 2026 at 11:10 AM
l2plabs.bsky.social
China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
CRANBURY, N.J. and SUZHOU, China, May 28, 2026 /PRNewswire/ -- Porton Advanced, a leading cell and gene therapy CDMO, recently announced its client Salvectors has received Investigational New Drug (IND) clearance for their proprietary and innovative oncolytic bacteria therapy, "YB1-X7...
dlvr.it
May 28, 2026 at 1:03 PM
l2plabs.bsky.social
China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
SUZHOU, China and CRANBURY, N.J., May 28, 2026 /PRNewswire/ -- Porton Advanced, a leading cell and gene therapy CDMO, recently announced its client Salvectors has received Investigational New Drug (IND) clearance for their proprietary and innovative oncolytic bacteria therapy, "YB1-X7...
dlvr.it
May 28, 2026 at 11:13 AM